Ritter Daniher Financial Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Ritter Daniher Financial Advisory’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-51	Closed	-$1.06K	–	338
2025 Q1	$1.06K	Hold	51	–	–	﹤0.01%	293
2024 Q4	$1.2K	Hold	51	–	–	﹤0.01%	290
2024 Q3	$1.31K	Hold	51	–	–	﹤0.01%	289
2024 Q2	$1.2K	Hold	51	–	–	﹤0.01%	288
2024 Q1	$1.47K	Hold	51	–	–	﹤0.01%	279
2023 Q4	$1.67K	Hold	51	–	–	﹤0.01%	315
2023 Q3	$1.42K	Hold	51	–	–	﹤0.01%	317
2023 Q2	$1.74K	Hold	51	–	–	﹤0.01%	290
2023 Q1	$1.53K	Hold	51	–	–	﹤0.01%	266
2022 Q4	$1.44K	Hold	51	–	–	﹤0.01%	256
2022 Q3	$2K	Hold	51	–	–	﹤0.01%	216
2022 Q2	$2K	Buy	+51	New	+$1.78K	﹤0.01%	217

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ritter Daniher Financial Advisory's ARKG Position: Q2 2025 in Review

Ritter Daniher Financial Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 51 shares — an estimated $1.06K sold.

Ritter Daniher Financial Advisory first reported a position in ARKG in Q2 2022 and held it in 12 quarters. The position peaked at $2K in Q3 2022. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

Ritter Daniher Financial Advisory reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
Ritter Daniher Financial Advisory sold 51 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $1.06K.
Ritter Daniher Financial Advisory first reported a position in ARK Genomic Revolution ETF in Q2 2022 and held it in 12 quarters.
Ritter Daniher Financial Advisory's ARK Genomic Revolution ETF position peaked at $2K in Q3 2022.
213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2025, filed 11 Aug 2025.